SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE

摘要

Pharmaceutical compositions of topiramate for once-±-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a predetermined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.